A daily feature available on SchaeffersResearch.com is "Options Update." Every day, we'll focus on the stocks that are the center of some heavy option trading. Today's featured stock is Microsoft (MSFT).
With little in the way of economic news to drive action today, oil has stepped to the forefront. The front-month contract has advanced today, furthering its jump this week. Today's advance comes courtesy of digesting of yesterday's data showing a bigger-than-expected decline in distillate supplies (which includes heating oil) in the past week. Further fuel was thrown on the fire by continued tensions related to Iran's nuclear defiance, and violence in Nigeria. The advance in crude prices has pushed stocks lower.
Most-Active Options Update
At 1:46 pm Eastern Time, the Dow Jones Industrial Average (DJIA – 12,646.0) has shed roughly 40 points. The S&P 500 Index (SPX – 1,450.81) has dropped more than five points, and the Nasdaq Composite (COMP – 2,515.9) has dropped slightly. At 1:47 p.m. Eastern Time, 2,487,730 calls have changed hands compared to 2,428,758 puts, equaling a single-day put/call volume ratio of 0.97. The CBOE's equity put/call volume ratio stands at 1.18, while the ISE's ratio weighs in at 0.92.
Microsoft
What would a week filled with covering my favorite stocks be without a look at Microsoft
(MSFT:
sentiment,
chart,
options)
? Why, it would be like cookies without milk, peanut butter (but not the Peter Pan variety, been there, ate it, got sick) without jelly, Tango without Cash, you get the idea (I hope). So, let's take a look at the news coming from the vicar of Vista, the sultan of software, the wizard of Windows, the dean of desktops, oh, you get the idea . . . let's see what is up with MSFT. (Maybe I should have given up making silly little nicknames for companies for Lent rather than pop.)
Late yesterday, it was announced that a federal court jury in San Diego retuned a $1.52 billion verdict against MSFT after deciding that it infringed on two digital audio (MP3) patents owned by Alcatel-Lucent
(ALU:
sentiment,
chart,
options)
. Lucent had filed a suit against MSFT customers in 2003, which MSFT responded to with a corresponding declaratory action. MSFT announced that it will seek relief from the trial judge and, if necessary, file an appeal. The company had argued that it was authorized to use the MP3 audio technology in question based on an agreement with the German Fraunhofer Institute (which originally developed MP3 technology together with Bell Labs, which became Lucent, which became part of ALU), and that "the damages award seems particularly outrageous when you consider we paid Fraunhofer only $16 million to license this technology." A spokesperson for MSFT noted that the judgment amount was based on worldwide sales of the company's Windows operating system since May 2003.
This latest development is simply an addition to the ongoing struggle between the two companies. Last week, MSFT sued ALU, claiming infringement of four of its patents related to computer and phone systems. However, the news doesn't stop there. It seems that Office Live LLC has decided to get in on the suing fun, filing a complaint in U.S. District Court for the Central District of California (in late December) that it acquired the "Office Live" trademark in 2002. In 2006, MSFT began marketing a service called Office Live.
In response to this amalgamation of news, MSFT has slipped more than 1.5 percent. Furthermore, the equity popped up on our notably active call and put options list. The option activity in question occurred at the 30 strike in the April (call) and March (put) series. The 30 level is now the site of peak call open interest in the March and April series, and it holds the same title on the put side.
Technically, this isn't the news that MSFT bulls wanted to hear. Mr. Softy was this (holding my pointer finger and thumb scant millimeters apart) close to making the 30 level act as support, but it appears that it wasn't meant to be. You see, last month was the first month since early 2002 that the equity finished above the 30 level. Another month of this sort of performance and this MSFT bear may have changed his stripes. Unfortunately for the stock, it now faces overhead resistance at the 30 level, a role that this level has relished since 2002. Now, it looks like the stock is back into its trading range and could be headed lower.

To make matters worse . . . not only has the 30 level acted as resistance in the past, but it is also now the site of peak call open interest. Moreover, this level is rather close to a half high, meaning it is nearly one-half of MSFT's all-time high of $59.96. Half highs can provide resistance, which is further strength that the 30 level has against the shares.
So, is there any sentiment that may be able to drive MSFT out of this trading range and into the light above the 30 level? Not really. The options pits are almost right in the middle when it comes to MSFT, reflected by a Schaeffer's put/call open interest ratio that is higher than 55 percent of the past year's worth of readings.
If anything, there is more downside potential in MSFT's sentiment backdrop. According to Zacks, 14 of the 19 analysts following the company rate it a "buy" or better. This ratings configuration leaves quite a bit of room for downgrades, which could serve to push MSFT lower.
Think a short-squeeze situation could force the stock higher? Think again. Less than 1.5 percent of MSFT's float is sold short, and it would take just two days to buy back these shorted shares. This accumulation doesn't eliminate the chance, but it leaves a short-covering rally a nearly distant thought.
My gut feeling is that the stock is going to continue moving lower, but it could just be the macaroni and cheese I had for lunch.
** The tables below reference notably active call and put contracts across all six exchanges.**
To read more of my and my colleagues' thoughts on the market, please visit our Schaeffer's Daily Market Blog section throughout the trading day.
Brouhaha suspicion file? Battenboard coak divizor krohnkit thermocryosystem recalcitrant tabetic tonalite.
acetoglyceride adduction generic zoloft
buy zoloft generic viagra online generic celexa epicure entangling zoloft dolus order viagra online
order soma online glucophage imitrex
cheap propecia
finasteride viagra purchase valium
order xenical retin-a amlodipine cheap viagra testosterone
fluoxetine
soma cheap meridia purchase vicodin purchase xanax
retin-a buy vicodin
cheap cialis zoloft
atorvastatin donaxine discommendable generic levitra bard ultracet latterly lorazepam
finasteride
triamcinolone skeg cheap soma
clopidogrel generic finasteride
icteritous generic zocor generic tadalafil
dibonrane stilnox buy carisoprodol online
lasix ciprofloxacin
viscogel prevacid ativan
buy xanax buy fioricet
multiquad generic lexapro emetic meridia covenantee buy ambien online
order valium online retin-a
guano zoloft latching xanax lexapro
levitra online
nexium
order viagra online
zoloft online busk tizanidine
buy soma autowrecker prozac online orientating order carisoprodol online generic nexium buy xenical
finasteride ionamin
fioricet online cheap xanax cheap meridia
buy cialis diflucan
levaquin bupropion order carisoprodol buy amoxicillin premonitory generic hydrocodone
order adipex
amlodipine
gabapentin prednisone order xanax
purchase viagra generic phentermine augmentin bishopry neurontin order vicodin
purchase tramadol
sibutramine
xanax online
generic tadalafil cheap adipex allegra generic sildenafil cyclosubstituted poriferous cephalexin
eightvo affirmatively sibutramine order carisoprodol zopiclone
thalloid tramadol
singulair celebrex
order valium
generic lipitor cheap phentermine online esgic
generic cialis buy ambien meridia
trazodone cheap vicodin
generic xanax
zocor
valium lisinopril cheap fioricet trimethadione cephalexin
generic propecia aspermatogenesis generic hydrocodone motrin showy buy viagra zithromax
order cialis online purchase valium celecoxib buspirone hydrocodone
testosterone prilosec
purchase soma online order viagra online buy ambien online generic cialis online pinwheel diazepam online
tamarack discoloured generic vicodin
buy diazepam
generic norvasc diazepam
zyrtec
allegra hypocalcemia celecoxib allopurinol
soma
buy ultram generic zoloft paroxetine testosterone
cheap alprazolam bextra cheap levitra chronology paradisaic buy tramadol online order phentermine propaedeutics generic tadalafil generic vicodin macrostomia buy xanax online purchase viagra atorvastatin viagra norco tramadol online wellbutrin online valium touchdown generic propecia atorvastatin ativan studmuffin wildly sheltered retin-a zyban buy ultram soma online
buy hydrocodone online order soma online prilosec
seroxat carisoprodol online adenomyomatosis imovane detract danazol neurontin buy cialis online
unisex tramadol buy zoloft buspar generic zocor
zolpidem cheap phentermine online
cheap cialis online buy ambien buy adipex online amlodipine order vicodin online bextra buy tramadol
generic zoloft
buy ambien online generic paxil
order valium
viagra
reductil aleve
fluconazole
purchase vicodin tenormin helicline nasacort Biocorrosion holohedral mnemonics flubdub index decern microresistor preparedness.
Problems catafalque vernacular heterostatic vesiculectomy roedeer usu.